Rat α-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex

被引:88
作者
Ghee, M
Fournier, A
Mallet, J
机构
[1] Hop La Pitie Salpetriere, Lab Gent Mol Neurotransmiss & Proc Neurdegenerat, CNRS, UMR 9923, F-75013 Paris, France
[2] Aventis Pharma Res & Dev, Vitry Sur Seine, France
关键词
alpha-synuclein; Parkinson's disease; Tat binding protein 1;
D O I
10.1046/j.1471-4159.2000.0752221.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The alpha-synuclein gene, which encodes a brain presynaptic nerve terminal protein of unknown function, is linked to familial early-onset Parkinson's disease (PD). The finding that alpha-synuclein forms the major fibrillary component of Lewy bodies in brains of PD patients suggests that the two point mutations in alpha-synuclein (Ala(53)Thr, Ala(30)Pro) may promote the aggregation of alpha-synuclein into filaments. To address the role of alpha-synuclein in neurodegenerative diseases, we performed a yeast two-hybrid screen of a rat adult brain cDNA library using rat alpha-synuclein 2 (alpha SYN2). Here we report that alpha SYN2 interacts specifically with Tat binding protein 1, a subunit of the 700-kDa proteasome activator (PA700), the regulatory complex of the 26S proteasome and of the modulator complex, which enhances PA700 activation of the proteasome.
引用
收藏
页码:2221 / 2224
页数:4
相关论文
共 30 条
[1]   Structural and functional effects of PA700 and modulator protein on proteasomes [J].
Adams, GM ;
Falke, S ;
Goldberg, AL ;
Slaughter, CA ;
DeMartino, GN ;
Gogol, EP .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (03) :646-657
[2]  
Bartel P, 1993, CELLULAR INTERACTION, P153
[3]   Degradation of α-synuclein by proteasome [J].
Bennett, MC ;
Bishop, JF ;
Leng, Y ;
Chock, PB ;
Chase, TN ;
Mouradian, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :33855-33858
[4]   Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease [J].
BilangBleuel, A ;
Revah, F ;
Colin, P ;
Locquet, I ;
Robert, JJ ;
Mallet, J ;
Horellou, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8818-8823
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[7]  
DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878
[8]   Identification, purification, and characterization of a PA700-dependent activator of the proteasome [J].
DeMartino, GN ;
Proske, RJ ;
Moomaw, CR ;
Strong, AA ;
Song, XL ;
Hisamatsu, H ;
Tanaka, K ;
Slaughter, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3112-3118
[9]  
DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059
[10]   TAT-BINDING PROTEIN-7 IS A SUBUNIT OF THE 26S PROTEASE [J].
DUBIEL, W ;
FERRELL, K ;
RECHSTEINER, M .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1994, 375 (04) :237-240